Changeflow GovPing Healthcare & Life Sciences Pressed Powder Patent, Shanghai Marshmallowmake...
Routine Rule Added Final

Pressed Powder Patent, Shanghai Marshmallowmakeup Biotech

Favicon for changeflow.com USPTO Patent Grants - Pharma (A61K)
Published
Detected
Email

Summary

USPTO granted Patent US12605309B2 to Shanghai Marshmallowmakeup Biotech Corp., Ltd on April 21, 2026 for a pressed powder product and its method of preparation. The invention comprises a pressed powder layer, an ink absorbing layer formed by spraying ink-absorbing paint, and a pattern layer obtained by printing. The ink-absorbing paint contains 0.5% to 10% by weight of an oil controlling agent, 0.5% to 20% by weight of a color developing agent, 55% to 98.5% by weight of a solvent, and 0.5% to 10% by weight of a stabilizer. The patent claims priority to Application No. 18201776 filed May 25, 2023, with 8 total claims granted.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Grants - Pharma (A61K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 22 changes logged to date.

What changed

USPTO granted Patent US12605309B2 to Shanghai Marshmallowmakeup Biotech Corp., Ltd for a pressed powder product and associated preparation method. The patented invention comprises three layers: a pressed powder layer, an ink absorbing layer, and a pattern layer obtained by printing. The ink absorbing paint formulation specifies precise weight percentages for each component. The preparation method involves uniformly mixing the oil controlling agent, color developing agent, solvent, and stabilizer, spraying the mixture onto the pressed powder layer, drying to form a semi-manufactured product, and printing a pattern.

Manufacturers developing pressed powder cosmetic products should review the granted claims to assess potential overlap with their existing product development activities. The specific compositional ranges and layer structure described in the patent may inform prior art considerations for competitive product development and patent clearance strategies.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Pressed powder product and method for preparing the same

Grant US12605309B2 Kind: B2 Apr 21, 2026

Assignee

Shanghai Marshmallowmakeup Biotech Corp., Ltd

Inventors

Hongwei Gu, Haifeng Qin, Huaicheng Yu

Abstract

A pressed powder product and a method for preparing the same are provided. The pressed powder product includes a pressed powder layer, an ink absorbing layer and a pattern layer. The pattern layer is obtained by printing. The ink absorbing layer is formed by spraying an ink-absorbing paint on the pressed powder layer. The ink-absorbing paint includes 0.5% to 10% by weight of an oil controlling agent, 0.5% to 20% by weight of a color developing agent, 55% to 98.5% by weight of a solvent, and 0.5% to 10% by weight of a stabilizer. The method for preparing the pressed powder product includes: uniformly mixing an oil controlling agent, a color developing agent, a solvent, and a stabilizer to obtain the mixture; spraying the mixture on a pressed powder layer, and drying to obtain a semi-manufactured pressed powder product; and, printing a pattern on the semi-manufactured pressed powder product.

CPC Classifications

A61K 8/022 A61K 2800/592 A61K 8/25 A61K 2800/52 A61K 2800/651 A61Q 1/12 A61Q 1/10

Filing Date

2023-05-25

Application No.

18201776

Claims

8

View original document →

Get daily alerts for USPTO Patent Grants - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 21st, 2026
Instrument
Rule
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12605309B2

Who this affects

Applies to
Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent grant IP registration
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Chemical Manufacturing

Get alerts for this source

We'll email you when USPTO Patent Grants - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!